The UCL BRC Cancer theme seeks proposals for grants to pump-prime experimental medicine research aligned to one of our three strategic objectives (see below) or in the area of early detection of cancer. The applications will be assessed on scientific quality and the likelihood that the award will lead to further funding from grant-giving bodies. There should be a clear and credible plan for downstream grant applications predicated on the results of research funded through this scheme.
The MRC invites researchers to apply for the Experimental Medicine Challenge Grants (EMCG) initiative, which supports research into disease pathophysiology conducted in humans.
The initiative aims to fund ambitious research programmes that generate a new and deeper understanding of human disease mechanisms and identify new therapeutic targets, so accelerating translational medicine.
The UCLH BRC Inflammation, Immunity and Immunotherapeutics Theme (III) recently awarded grants to support research proposals for translational research closely aligned to the III Theme’s strategy.
The theme received a total of 22 applications, of which 12 were shortlisted. After a rigorous scoring process by the BRC III Board and external reviewers, 8 applications (listed below) have been granted funding to the tune of £528K.
The proposals submitted had to meet three key objectives:
Small awards of up to £40,000 are made to enable researchers to assemble pilot data on which to build larger grant applications to external funding bodies.
The BRC is looking for early stage researchers to pilot different ways of involving patients and the public in basic research as part of a groundbreaking collaborative with 4 research charities.
BRU and BRC supported researchers have demonstrated that dementias previously thought to be ‘language-led’, also extend to areas of the brain related to sound.